Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
Haematologica|November 4, 2006
Treatment-related myelodysplasia following fludarabine combination chemotherapyConstantine S Tam, John F Seymour, H Miles Prince, et al.
Inorganic Chemistry|December 2, 2025
Positional Tuning of Photophysics and Catalysis in Methoxy-Substituted Heteroleptic Copper(I) ComplexesKurt J Haseloff, Katharina Rediger, Mohammad D Mandourah, et al.
Proceedings. Biological Sciences|July 10, 2008
Mammalian choices: combining fast-but-inaccurate and slow-but-accurate decision-making systemsPete C Trimmer, Alasdair I Houston, James A R Marshall, et al.
Trends in Cognitive Sciences|January 29, 2014
The evolution of decision rules in complex environments, Tim W Fawcett, Benja Fallenstein, et al.
Leukemia & Lymphoma|July 16, 2005
Ante-mortem diagnosis of localized invasive esophageal aspergillosis in a patient with acute myeloid leukemiaFiona Chionh, Kirsten E Herbert, John F Seymour, et al.
Cancer|May 2, 2006
Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphomaConstantine S Tam, Max Wolf, H Miles Prince, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2005
A phase Ib clinical trial of PV701, a milk-derived protein extract, for the prevention and treatment of oral mucositis in patients undergoing high-dose BEAM chemotherapyH Miles Prince, Geoff Regester, Priscilla Gates, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2016
Boosting medical diagnostics by pooling independent judgmentsRalf H J M Kurvers, Stefan M Herzog, Ralph Hertwig, et al.
The American Journal of Medicine|March 15, 2002
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphomaAndrew Wirth, John F Seymour, Rodney J Hicks, et al.
Leukemia & Lymphoma|March 12, 2010
Phase II study of autologous stem cell transplant using busulfan-melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphomaAndrew P Grigg, Janey Stone, Alvin D Milner, et al.
Pageof 16